Drug, Discovery & Development recently published a piece by Data2Life CEO Itzik Lichtenfeld, exploring how understanding the history of pharmacovigilance can help leaders in the industry develop a road map to the future. In The Past, Present and Future of Pharmacovigilance, Itzik writes,

Yes, marketing groups have had their eyes and ears on social media for some time, and researchers have been using advanced toolsets to crunch huge data volumes that originated mainly from clinical studies. But today the game is also changing for pharmacovigilance (PV) and drug safety teams that have been protected from disruption by strong regulatory oversight and the industry’s traditionally risk-averse culture.

The case of teething gels, which we’ve illustrated in our typical timeline of drug events infographic, demonstrates that “‘real-world’ inputs can signal serious drug effects, improve future monitoring and speed the time to action.”

Check out the full article on the Drug, Discovery & Development website.